The Riverside Company Invests in EventsAIR

The Riverside Company Makes Growth Investment in Cloudpermit

September 10, 2024

Cloud & SaaS

The Riverside Company has made a growth investment in Cloudpermit, a North American govtech SaaS provider that streamlines building permitting, inspections, licensing and related community development processes. The capital will support product and capability expansion — including enhanced BIM and AI features — and help Cloudpermit broaden its presence across the U.S., Canada and Finland.

The Riverside Company Invests in Virtual IT Group

June 21, 2024

IT Services

The Riverside Company has signed a definitive agreement to make an investment in Australian managed service provider Virtual IT Group (VITG). The growth capital will support VITG's platform expansion, organic growth and M&A activity while founder Christian Pacheco remains Managing Director and a significant shareholder.

The Riverside Company Invests in CRIO, Inc.

May 21, 2024

Cloud & SaaS

The Riverside Company, via its Riverside Micro-Cap Fund, has made a growth investment in CRIO, Inc., a Boston-based provider of cloud-based eSource, CTMS and regulatory-compliance software for clinical trial sites, CROs and pharmaceutical/biotech sponsors. Riverside’s capital will support accelerated product development, broader product offerings and potential strategic acquisitions as CRIO scales.

The Riverside Company Invests in Impact XM

December 20, 2023

Marketing & Advertising

The Riverside Company, a global private equity firm, has completed an investment in the parent company of Impact XM, a full-service experiential marketing and event production agency. Riverside said the partnership will accelerate Impact XM’s domestic and international growth and expand its capabilities across live events, corporate activations and brand experiences.

The Riverside Company Invests in Avance Clinical

November 9, 2021

Healthcare Services

The Riverside Company has invested in Avance Clinical, a leading Australian contract research organisation (CRO), to support the company's regional and international expansion. The investment will help Avance accelerate its clinical trials business — including vaccine and gene-technology studies — with a particular focus on growth in North America and Asia.

The Riverside Company Invests in Altius Group Holdings

January 21, 2021

Healthcare Services

The Riverside Company has agreed to make an investment in Altius Group Holdings (Altius), an Australian provider of allied health and workplace rehabilitation services led by founder Derick Borean. Riverside will partner with the Altius team to expand the company's geographic footprint across Australia and broaden its physical and psychological health and wellbeing services to corporate, government and NDIS clients.